^SAMPLE = GSM601564!Sample_title = Early stage ovarian carcinoma T117!Sample_geo_accession = GSM601564!Sample_status = Public on Aug 22 2012!Sample_submission_date = Sep 28 2010!Sample_last_update_date = Aug 22 2012!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = Tumor!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = gender: Female!Sample_characteristics_ch1 = tissue: ovarian carcinoma tissue!Sample_characteristics_ch1 = sample: T117!Sample_characteristics_ch1 = age: 50!Sample_characteristics_ch1 = Stage: Ic ascites positive!Sample_characteristics_ch1 = type: S!Sample_characteristics_ch1 = grade: 1!Sample_characteristics_ch1 = ct: no!Sample_characteristics_ch1 = status: Dead!Sample_characteristics_ch1 = os (months): 61!Sample_characteristics_ch1 = progression: yes!Sample_characteristics_ch1 = pfs (months): 7!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = DNAzol (Invitrogen) according to manufacturer's protocol!Sample_label_ch1 = Cy5!Sample_label_protocol_ch1 = DNA labeling protocol according to Enzo Life Sciences!Sample_source_name_ch2 = Female reference DNA!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = gender: Female!Sample_characteristics_ch2 = tissue: blood pooled from 18 healthy individuals!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = DNAzol (Invitrogen) according to manufacturer's protocol!Sample_label_ch2 = Cy3!Sample_label_protocol_ch2 = DNA labeling protocol according to Enzo Life Sciences!Sample_hyb_protocol = Hybridization protocol available via www.agilent.com!Sample_scan_protocol = Slides were scanned using the Agilent microarray scanner, protocol according to Agilent.!Sample_description = reference DNA is pooled DNA from the blood of 18 healthy individuals!Sample_description = raw data files: MAL_251901510439_S01_CGH-v4_95_Feb07_1_1.txt, MAL_251901510439_S01_CGH-v4_95_Feb07_1_2.txt!Sample_data_processing = Dewaving: The data have been de-waved as described in Van de Wiel et al. (2009) using the R package NoWaves. This is available from www.few.vu.nl/~mavdwiel/nowaves.html. Agilent 105K normals were used as calibration. Normalization: mode normalization.!Sample_platform_id = GPL8693!Sample_contact_name = Daoud,,Sie!Sample_contact_email = d.sie@vumc.nl!Sample_contact_phone = +31 20 4442428!Sample_contact_laboratory = Microarray Core Facility!Sample_contact_department = Pathology!Sample_contact_institute = Vrije Universiteit Medical Center!Sample_contact_address = De Boelelaan 1117!Sample_contact_city = Amsterdam!Sample_contact_zip/postal_code = 1081 HV!Sample_contact_country = Netherlands!Sample_supplementary_file = NONE!Sample_series_id = GSE24418!Sample_data_row_count = 98641#ID_REF = #VALUE = log2 normalized ratio tumor/ref!sample_table_beginID_REF	VALUE21395	0.8942360251079410739	-0.87111891256273104425	0.086563573602400232153	1.627131954965190988	0.6408068918621821003	-0.4005834232467239983	0.5947104772727272110	0.521624792733644222	-0.6503215107816618824	0.2486203317113742407	0.7800256806218745298	0.142374436570975519	-0.80365961562838474	-0.2246917311303623466	-0.2800960737032923742	-0.1077711727442192839	0.2153183565605443522	-0.48318355733906101129	-0.8398176329562146354	0.0582891196072204!sample_table_end